The Defiance Quantum ETF (NYSEARCA:QTUM) has become the default way to buy the quantum theme. It is up 40.5% year to date against the S&P 500’s 14.1%, assets have crossed roughly $6 billion, and the fund carries a 0.40% expense ratio. QTUM’s run is drawing new attention, and much of that attention arrives with a question: why hold a basket when a name like IonQ (NYSE:IONQ | IONQ Price Prediction) sits inside the basket and represents the pure-play version of the same bet? The temptation is to trade QTUM for the single stock. The numbers argue against it.
QTUM tracks an equal-weight index of roughly 70 to 75 companies touching quantum computing, machine learning, and advanced computing hardware. Equal weighting is the important part. No single holding dominates, and rebalancing forces the fund to trim winners and add to laggards. That mechanic is why QTUM has captured the theme without living or dying on any one chip roadmap.
Why the Single-Stock Swap Looks Tempting
IonQ is probably the name you hear the most in quantum computing right now. Their second-quarter revenue came in at $80.1 million, a 287% year-over-year jump, and management already bumped full-year guidance up to a range of $280 million to $290 million. Remaining performance obligations ended the quarter at $485 million, up from just $122 million a year earlier. Right before the earnings report, the company closed its $1.8 billion acquisition of SkyWater, which gives it a domestic quantum foundry, and CEO Niccolo de Masi called it “the strongest quarter in our company’s history.” The narrative is definitely real. Even Reddit sentiment on the name sits at a quarterly average score of 74, which is categorized as bullish.
Where the Numbers Stop Cooperating
Concentrated bets on a theme only pay when the concentrated bet outperforms the theme, which has not been the case in 2026. Year-to-date through August 24, IonQ shares are down 8.49%, going from $44.87 at the end of 2025 to $41.06. Over the same window, QTUM returned 34.49% on a total-return basis. On a one-year view, IonQ is up 3.22% while QTUM is up 57.75%. A holder who sold QTUM at the start of 2026 to concentrate in IonQ gave up more than 40 percentage points of return in eight months, on the exact thesis they were trying to express.
The broader quantum fund captured gains from adjacent semiconductor, HPC, and quantum-hardware names, while the pure-play name absorbed dilution from a $2 billion equity offering, warrant remeasurement, and the SkyWater deal. The company reported a Q2 GAAP net loss of $1.87 billion, driven largely by a roughly $1.6 billion non-cash warrant mark, plus $141.8 million of stock-based compensation in that same quarter. Trailing P/E sits at negative 33, and operating margin is negative 487%. None of that invalidates the roadmap or the long-term story, but it does explain why the stock has lagged the very theme it defines.
What the Swap Would Actually Change
Trading QTUM for IonQ is a dramatic move. You are compressing exposure from roughly 70 companies down to just one, and that changes your risk profile in three very specific ways. First, revenue concentration. IonQ’s entire FY2026 revenue guide of $280 million to $290 million is just a fraction of the combined revenue sitting inside QTUM’s broader index. Second, balance-sheet volatility. Just warrant marks alone can create billion-dollar swings in reported GAAP earnings from one quarter to the next, so earnings reports become a wild ride. Third, timeline risk. IonQ’s 256-qubit system is targeted for commissioning in the first half of 2027, with 10,000-qubit chips beginning tape-out. A slip on either of those milestones pushes the story right and the stock along with it.
QTUM’s 0.40% fee is not free, and equal weighting can lag in years when one mega-cap runs away from the field. Neither drag has shown up in the 2026 return profile.
How to Think About It From Here
For a holder who owns QTUM as a diversified quantum sleeve, the case for a full swap into IonQ is weak on the evidence. A partial position, sized as a satellite around a QTUM core, is a different conversation. It preserves basket exposure while adding concentrated upside if IonQ hits its 2027 milestones. Taxable holders would also face a capital gain from selling QTUM after its run, which can absorb a meaningful portion of any expected edge from the switch.
Weighing the Trade Right Now
The field has been beating the stock-picker in 2026 by roughly the width of QTUM’s outperformance over IonQ. Investors who bought QTUM for diversified quantum exposure are getting exactly what they paid for. Trading it for a single name, however compelling that name’s roadmap, is a different investment. The right question is whether the marginal dollar belongs in the basket that has already worked or in a name that needs its next milestone to catch up.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks